Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy

被引:60
作者
Asmuth, David M. [1 ,2 ]
Ma, Zhong-Min [3 ,4 ]
Albanese, Anthony [2 ]
Sandler, Netanya G. [5 ]
Devaraj, Sridevi [6 ,7 ]
Knight, Thomas H. [1 ]
Flynn, Neil M. [1 ]
Yotter, Tammy [1 ]
Garcia, Juan-Carlos [1 ]
Tsuchida, Emily [8 ]
Wu, Tsung-Teh [9 ]
Douek, Daniel C. [5 ]
Miller, Christopher J. [2 ,3 ]
机构
[1] Univ Calif Davis, Davis Med Sch, Sacramento, CA 95817 USA
[2] Vet Adm Northern Calif Healthcare Syst, Sacramento, CA USA
[3] Univ Calif Davis, Davis, CA 95817 USA
[4] Ctr Comparat Med, Davis, CA USA
[5] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[6] Baylor Coll Med, Houston, TX 77030 USA
[7] Texas Childrens Hosp, Houston, TX 77030 USA
[8] CARES Clin, Sacramento, CA USA
[9] Mayo Clin, Rochester, MN USA
基金
美国国家卫生研究院;
关键词
bovine immunoglobulin; d-xylose absorption; gastrointestinal associated lymphoid tissue; gut permeability; HIV enteropathy; immune reconstitution; immunohistochemistry; intestinal fatty acid binding protein; monocyte chemotaxis protein-1; LYMPHATIC TISSUE FIBROSIS; T-CELL DEPLETION; INTESTINAL BARRIER FUNCTION; DIETARY PLASMA-PROTEINS; DRIED PORCINE PLASMA; LYMPHOID-TISSUE; COLLAGEN DEPOSITION; BACTERIAL TRANSLOCATION; GASTROINTESTINAL-TRACT; ANIMAL PLASMA;
D O I
10.1097/QAD.0b013e328362e54c
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives:To examine the impact of serum-derived bovine immunoglobulin, an oral medical food known to neutralize bacterial antigen and reduce intestinal inflammation, on restoration of mucosal immunity and gastrointestinal function in individuals with HIV enteropathy. Design:Open-label trial with intensive 8-week phase of bovine serum immunoglobulin (SBI) 2.5g twice daily with a 4-week washout period and an optional 9-month extension study. Methods:HIV enteropathy was defined as chronic gastrointestinal symptoms including frequent loose or watery stools despite no identifiable, reversible cause. Upper endoscopy for tissue immunofluorescent antibody assay and disaccharide gut permeability/absorption studies were performed before and after 8 weeks of SBI to test mucosal immunity and gastrointestinal function. Blood was collected for markers of microbial translocation, inflammation, and collagen kinetics. A validated gastrointestinal questionnaire assessed changes in symptoms. Results:All eight participants experienced profound improvement in symptoms with reduced bowel movements/day (P=0.008) and improvements in stool consistency (P=0.008). Gut permeability was normal before and after the intervention, but d-xylose absorption increased in seven of eight participants. Mucosal CD4(+) lymphocyte densities increased by a median of 139.5cells/mm(2) from 213 to 322cells/mm(2) (P=0.016). Intestinal-fatty acid binding protein (I-FABP), a marker of enterocyte damage, initially rose in seven of eight participants after 8 weeks (P=0.039), and then fell below baseline in four of five who continued receiving SBI (P=0.12). Baseline serum I-FABP levels were negatively correlated with subsequent rise in mucosal CD4(+) lymphocyte densities (r=-0.74, P=0.046). Conclusion:SBI significantly increases intestinal mucosal CD4(+) lymphocyte counts, improves duodenal function, and showed evidence of promoting intestinal repair in the setting of HIV enteropathy.
引用
收藏
页码:2207 / 2217
页数:11
相关论文
共 64 条
[1]   Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies [J].
Adriaanse, M. P. M. ;
Tack, G. J. ;
Passos, V. Lima ;
Damoiseaux, J. G. M. C. ;
Schreurs, M. W. J. ;
van Wijck, K. ;
Riedl, R. G. ;
Masclee, A. A. M. ;
Buurman, W. A. ;
Mulder, C. J. J. ;
Vreugdenhil, A. C. E. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (04) :482-490
[2]   Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens [J].
Asmuth, David M. ;
Ma, Zhong-Min ;
Mann, Surinder ;
Knight, Thomas H. ;
Yotter, Tammy ;
Albanese, Anthony ;
Melcher, Gregory P. ;
Troia-Cancio, Paolo ;
Hayes, Timothy ;
Miller, Chris J. ;
Pollard, Richard B. .
AIDS, 2012, 26 (13) :1625-1634
[3]   PHYSIOLOGICAL-EFFECTS OF HIV-INFECTION ON HUMAN INTESTINAL EPITHELIAL-CELLS - AN IN-VITRO MODEL FOR HIV ENTEROPATHY [J].
ASMUTH, DM ;
HAMMER, SM ;
WANKE, CA .
AIDS, 1994, 8 (02) :205-211
[4]   Effects of bovine serum concentrate, with or without supplemental micronutrients, on the growth, morbidity, and micronutrient status of young children in a low-income, peri-urban Guatemalan community [J].
Begin, F. ;
Santizo, M-C ;
Peerson, J. M. ;
Torun, B. ;
Brown, K. H. .
EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2008, 62 (01) :39-50
[5]   Intestinal inflammation, ileal structure and function in HIV [J].
Bjarnason, I ;
Sharpstone, DR ;
Francis, N ;
Marker, A ;
Taylor, C ;
Barrett, M ;
Macpherson, A ;
Baldwin, C ;
Menzies, IS ;
Crane, RC ;
Smith, T ;
Pozniak, A ;
Gazzard, BG .
AIDS, 1996, 10 (12) :1385-1391
[6]   INTESTINAL PERMEABILITY - AN OVERVIEW [J].
BJARNASON, I ;
MACPHERSON, A ;
HOLLANDER, D .
GASTROENTEROLOGY, 1995, 108 (05) :1566-1581
[7]  
BORDER WA, 1994, NEW ENGL J MED, V331, P1286
[8]   Microbial translocation is a cause of systemic immune activation in chronic HIV infection [J].
Brenchley, Jason M. ;
Price, David A. ;
Schacker, Timothy W. ;
Asher, Tedi E. ;
Silvestri, Guido ;
Rao, Srinivas ;
Kazzaz, Zachary ;
Bornstein, Ethan ;
Lambotte, Olivier ;
Altmann, Daniel ;
Blazar, Bruce R. ;
Rodriguez, Benigno ;
Teixeira-Johnson, Leia ;
Landay, Alan ;
Martin, Jeffrey N. ;
Hecht, Frederick M. ;
Picker, Louis J. ;
Lederman, Michael M. ;
Deeks, Steven G. ;
Douek, Daniel C. .
NATURE MEDICINE, 2006, 12 (12) :1365-1371
[9]   Impact of irradiation and immunoglobulin G concentration on absorption of protein and immunoglobulin G in calves fed colostrum replacer [J].
Campbell, J. M. ;
Russell, L. E. ;
Crenshaw, J. D. ;
Weaver, E. M. ;
Godden, S. ;
Quigley, J. D. ;
Coverdale, J. ;
Tyler, H. .
JOURNAL OF DAIRY SCIENCE, 2007, 90 (12) :5726-5731
[10]   Matrix metalloproteinases and their inhibitors as markers of inflammation and fibrosis in chronic liver disease [J].
Consolo, M. ;
Amoroso, A. ;
Spandidos, D. A. ;
Mazzarino, M. C. .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2009, 24 (02) :143-152